The credit consists of a $15 million growth capital term loan, a $30 million undrawn line of credit, and a $5 million accordion feature.

The Saber-C system combines the stability of traditional anterior cervical plating with a zero-profile interbody construct.

VersaLift offers one of the smallest starting heights available for a TLIF expandable interbody implant, beginning at just 6mm.

MISHA is shown to be effective for knee OA patients who failed non-surgical treatments, but are not indicated or are unwilling to get a knee replacement.

The project is on track to reach the next milestone toward CE Mark approval of HyProtect-coated revision implants.

FDA approved an IDE application for a pivotal clinical trial of SOLA-2 Alternating Magnetic Field System in patients with periprosthetic joint infections.

This marks the company’s entry into the U.S. bone graft substitute market, and represents the first clearance of a device based on its proprietary JAZBI biomaterial.

HyperPlate fixation technology advances the SpeedPlate implant platform by incorporating FastPitch locking screws into the titanium compression implants.

Acquisition of the system, indicated for supplemental fusion of the non-cervical spine, is complete and U.S. launch has commenced.

The study evaluates VCFix used with or without bone cement, expanding clinical experience with the company’s minimally invasive spine platform.